Offer - Urjas Oil for just ₹ 1 X
Ikgdar 500 Injection is a prescription drug, available for use as Injection. Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia are some of its major therapeutic uses. Ikgdar 500 Injection also has some secondary and off-label uses. These are listed below.
The optimal dosage of Ikgdar 500 Injection is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
The side effects typically associated with Ikgdar 500 Injection include Weakness. Some other side effects of Ikgdar 500 Injection have been listed ahead. These side effects of Ikgdar 500 Injection are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
Ikgdar 500 Injection's effect during pregnancy is Moderate and Severe while nursing. Warnings related to Ikgdar 500 Injection's effects on the liver, heart and kidney, if any, have been listed below.
Ikgdar 500 Injection is not recommended if you suffer from certain medical conditions as it can have adverse effects. Hyperkalemia are examples of such conditions. Other conditions have been mentioned below in the Ikgdar 500 Injection contraindications section.
Drug reaction of Ikgdar 500 Injection with other medicines has been reported. See below for a complete list.
You should also be aware that Ikgdar 500 Injection is not safe while driving, and is not addiction.
Ikgdar 500 Injection is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Ikgdar 500 Injection safe for pregnant women?
Pregnant women may experience moderate side effects from Ikgdar. It is best to stop taking Ikgdar immediately and inform your doctor if you notice any discomfort.
Is the use of Ikgdar 500 Injection safe during breastfeeding?
Taking Ikgdar may lead to serious side effects if you are breastfeeding. Ikgdar should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Ikgdar 500 Injection on the Kidneys?
Ikgdar can have moderate side effects on the kidney. If you notice any harmful effects, stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Ikgdar 500 Injection on the Liver?
Using Ikgdar does not have any harmful effects on the liver.
What is the effect of Ikgdar 500 Injection on the Heart?
The heart can be affected by Ikgdar. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
If you are suffering from any of the following diseases, you should not take Ikgdar 500 Injection unless your doctor advises you to do so -
Is this Ikgdar 500 Injection habit forming or addictive?
No, you will not get addicted to Ikgdar 500 Injection.
Is it safe to drive or operate heavy machinery when consuming?
After taking Ikgdar 500 Injection, you should not drive or work on any heavy machine, as Ikgdar 500 Injection can make you drowsy.
Is it safe?
Yes, but take Ikgdar 500 Injection only as per medical advice.
Is it able to treat mental disorders?
No, Ikgdar 500 Injection cannot treat any kind of mental disorder.
Interaction between Food and Ikgdar 500 Injection
It is safe to take Ikgdar 500 Injection with food.
Interaction between Alcohol and Ikgdar 500 Injection
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Ikgdar 500 Injection.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rituxan (rituximab)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1106-1109
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 872